Get started
Author

Ana Rupérez

Observed names: A. Belén Rupérez, A. Rupérez, A.- B. Rupérez, ANA B. RUPÉREZ, Ana B. Rupérez, Ana Belen Ruperez, Ana Belén Rupérez, Ana Belén Rupérez Blanco, Ana Ruperez
ORCID: 0000-0003-2338-4257
Observed ORCID: 0000-0003-2338-4257
OpenAlex ID: A5004764246
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
2018 · Andrés J. Muñoz Martín, Israel Ortega, et al. · British Journal of Cancer · 141
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
2023 · Andrés Muñoz, Cihan Ay, et al. · Journal of Clinical Oncology · 71
PDF
Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2
2016 · ANDRÉS J. MUÑOZ MARTÍN, PILAR GARCÍA ALFONSO, et al. · Oncology Letters · 9
PDF
Evaluation of a Heredofamilial Cancer Unit in Increasing Family History Collection and Genetic Counseling Referrals Among Spanish Oncologists at a University Hospital
2013 · Iván Márquez‐Rodas, Sara López‐Tarruella, et al. · Journal of Genetic Counseling · 4
PDF
Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis
2025 · Lucía Mateos, Paula Jiménez-Fonseca, et al. · British Journal of Cancer · 3
PDF
Cancer-associated venous thromboembolism and its impact on survival in the ONCOTHROMB12-01 cohort study
2025 · Bárbara Lobato-Delgado, Magdalena Ruiz, et al. · IJC Heart & Vasculature · 3
Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated with a Novel Combination Treatment with Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab)
2019 · Jaime Rubio Perez, Roberto Hernández, et al. · Archives of Clinical and Medical Case Reports · 1
Prognostic and predictive factors in metastasic colorectal cancer.
2018 · Pilar Garcia Alfonso, Gonzalo Garcia, et al. · Journal of Clinical Oncology · 1
Treatment and Outcomes in Advanced Gastroesophageal Adenocarcinoma in the Pre-Immunotherapy Era Based on the Spanish AGAMENON-SEOM Registry
2025 · Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, et al. · Cancers
PDF
PB0931 Long-Term Performance of a Clinical-Genetic Risk Score of Venous Thromboembolism (VTE) in Cancer Patients
2023 · A. Muñoz Martín, M. Ruiz, et al. · Research and Practice in Thrombosis and Haemostasis
OC-01: Mortality impact of cancer-associated venous thromboembolism: final analysis from Oncothromb12-01 study
2022 · M. Ruiz, A. Muñoz Martín, et al. · Thrombosis Research
OC-13 A clinical-genetic risk score to predict cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
2021 · A. Muñoz, C. Ay, et al. · Thrombosis Research
Incidence of Thromboembolic Disease in a Cohort of Patients With Sarcoma
2019 · Carme Font, Laura Ortega Morán, et al.
DNA repair pathway alterations and correlation with immunotherapy response.
2019 · Tatiana Hernandez-Guerrero, Manuel Pedregal, et al. · Journal of Clinical Oncology
Intérêt des variants génétiques dans la prédiction du risque de thrombose associée au cancer
2019 · A. Muñoz, M. Ruiz, et al. · JMV-Journal de Médecine Vasculaire
MiR-148a deregulation and colorectal cancer liver metastases.
2018 · Jaime Rubio Pérez, Ion Cristobal, et al. · Journal of Clinical Oncology
Prophylaxis and treatment of venous thromboembolism: data on a survey amongst members of the Spanish Medical Oncology Society
2018 · C. Font, I. García-Escobar, et al. · Thrombosis Research
Prognostic value of molecular biomarkers in mCRC
2017 · Pilar García Alfonso, Gonzalo García González, et al. · Annals of Oncology
PDF
Phase II study of weekly carboplatin/gemcitabine + concurrent thoracic radiotherapy (RT) followed by consolidation carboplatin/gemcitabine for inoperable stage III non-small cell lung cancer (NSCLC).
2015 · Manuel Domine, Cristina Carames Sanchez, et al. · Journal of Clinical Oncology
Works count: 19
Citation count: 233
H-index: 4
I10-index: 2
Year
Topic
Type